MAPT and tauopathy: Knockdown of LRP1 was recently shown to block the uptake of monomeric and oligomeric tau in a human neuroglioma cell line, and partially inhibit uptake of sonicated tau fibrils (99), warranting further investigation into how astrocytic LRP1 may mediate tau uptake and spread in tauopathies.